DEVICE AND METHOD FOR PERFORMING REFRACTIVE SURGERY

Inventor: Josef Bille

Patented Case View Patent ↗ View Publication ↗

	Code	Description	Pages	PDF
2015-08-20	`SES.LOSS.ELC`	Notification of loss of entitlement to small entity status via Patent Application Information Retrieval (PAIR)	1	View
2001-10-12	`TRNA`	Transmittal of New Application	3	View
2001-10-12	`SPEC`	Specification	12	View
2001-10-12	`CLM`	Claims	4	View
2001-10-12	`ABST`	Abstract	1	View
2001-10-12	`DRW`	Drawings-only black and white line drawings	2	View
2001-10-12	`OATH`	Oath or Declaration filed	2	View

Inventors

Josef Bille Heidelberg, GERMANY

Attorneys & Agents of Record

NEIL NYDEGGER Reg. 30202 Attorney · NEIL K. NYDEGGER, ESQ.

Classification

USPC 606/5

Prosecution

Publication

Patent Term Adjustment

-64days

ATON PHARMA, INC., BAUSCH & LOMB INCORPORATED, BAUSCH & LOMB PHARMA HOLDINGS CORP., COMMONWEALTH LABORATORIES, LLC, DOW PHARMACEUTICAL SCIENCES, INC., ECR PHARMACEUTICALS CO., INC., LABORATOIRE CHAUVIN S.A.S., MEDICIS PHARMACEUTICAL CORPORATION, ONPHARMA INC., ORAPHARMA, INC., PRECISION DERMATOLOGY, INC., SALIX PHARMACEUTICALS, LTD., SALIX PHARMACEUTICALS, INC., SANTARUS, INC., SOLTA MEDICAL, INC., SYNERGETICS USA, INC., TECHNOLAS PERFECT VISION GMBH, VALEANT CANADA LP, VALEANT PHARMACEUTICALS INTERNATIONAL, VALEANT PHARMACEUTICALS INTERNATIONAL, INC., VALEANT PHARMACEUTICALS NORTH AMERICA LLC, WIRRA IP PTY LIMITED, VALEANT PHARMA POLAND SP. Z O.O., VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L., VALEANT PHARMACEUTICALS IRELAND LIMITED

from THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT

RELEASE OF SECURITY INTEREST Recorded 2025-11-20

BAUSCH HEALTH IRELAND LIMITED, BAUSCH HEALTH COMPANIES INC., BAUSCH HEALTH, CANADA INC., TECHNOLAS PERFECT VISION GMBH, VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L., VALEANT PHARMA POLAND SPOLKA Z ORGANICZONA ODPOWIEDZIALNOSCIA, VALEANT SP. Z.O.O.

from THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT

RELEASE OF SECURITY INTEREST Recorded 2025-11-20

BAUSCH & LOMB INCORPORATED, LABORATOIRE CHAUVIN S.A.S., TECHNOLAS PERFECT VISION GMBH, THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES

from THE BANK OF NEW YORK MELLON

OMNIBUS PATENT SECURITY RELEASE AGREEMENT (REEL/FRAME 045444/0634) Recorded 2022-11-02

BAUSCH & LOMB INCORPORATED, TECHNOLAS PERFECT VISION GMBH, THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, PF CONSUMER HEALTHCARE 1 LLC, LABORATOIRE CHAUVIN S.A.S.

from BARCLAYS BANK PLC

RELEASE OF SECURITY INTEREST IN SPECIFIED PATENTS (REEL/FRAME 045444/0299) Recorded 2022-10-26

THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT

from BAUSCH HEALTH COMPANIES INC., BAUSCH HEALTH IRELAND LIMITED, BAUSCH HEALTH, CANADA INC., TECHNOLAS PERFECT VISION GMBH, VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA, VALEANT PHARMACEUTICALS LUXEMBOURG S.À R.L., VALEANT SP. Z O. O.

INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded 2019-07-03

BARCLAYS BANK PLC, AS COLLATERAL AGENT

from ATON PHARMA, INC., BAUSCH & LOMB INCORPORATED, BAUSCH & LOMB PHARMA HOLDINGS CORP., COMMONWEALTH LABORATORIES, LLC, DOW PHARMACEUTICAL SCIENCES, INC., ECR PHARMACEUTICALS CO., INC., LABORATOIRE CHAUVIN S.A.S., MEDICIS PHARMACEUTICAL CORPORATION, ONPHARMA INC., ORAPHARMA, INC., PRECISION DERMATOLOGY, INC., SALIX PHARMACEUTICALS, INC., SALIX PHARMACEUTICALS, LTD., SANTARUS, INC., SOLTA MEDICAL, INC., SYNERGETICS USA, INC., TECHNOLAS PERFECT VISION GMBH, VALEANT CANADA LP, VALEANT PHARMA POLAND SP. Z O.O., VALEANT PHARMACEUTICALS INTERNATIONAL, VALEANT PHARMACEUTICALS INTERNATIONAL, INC., VALEANT PHARMACEUTICALS IRELAND LIMITED, VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L., VALEANT PHARMACEUTICALS NORTH AMERICA LLC, WIRRA IP PTY LIMITED

SECURITY INTEREST Recorded 2018-02-26

THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT